Potential single nucleotide polymorphisms (SNPs) were detected between two chicken breeds (Kashmir favorella and broiler) using deep RNA sequencing. This was carried out to comprehend the coding area alterations, which cause variances in the immunological response to Salmonella infection. In the present study, we identified high impact SNPs from both chicken breeds in order to delineate different pathways that mediate disease resistant/susceptibility traits. Samples (liver and spleen) were collected from Salmonella resistant (K. favorella) and susceptible (broiler) chicken breeds. Salmonella resistance and susceptibility were checked by different pathological parameters post infection. To explore possible polymorphisms in genes linked with disease resistance, SNP identification analysis was performed utilizing RNA seq data from nine K. favorella and ten broiler chickens. A total of 1778 (1070 SNPs and 708 INDELs) and 1459 (859 SNPs and 600 INDELs) were found to be specific to K. favorella and broiler, respectively. Based on our results, we conclude that in broiler chickens the enriched pathways mostly included metabolic pathways like fatty acid metabolism, carbon metabolism and amino acid metabolism (Arginine and proline metabolism), while as in K. favorella genes with high impact SNPs were enriched in most of the immune-related pathways like MAPK signaling pathway, Wnt signaling pathway, NOD-like receptor signaling pathway, etc., which could be a possible resistance mechanism against salmonella infection. In K. favorella, protein–protein interaction analysis also shows some important hub nodes, which are important in providing defense against different infectious diseases. Phylogenomic analysis revealed that indigenous poultry breeds (resistant) are clearly separated from commercial breeds (susceptible). These findings will offer fresh perspectives on the genetic diversity in chicken breeds and will aid in the genomic selection of poultry birds.
Salmonella Gallinarum causes fowl typhoid, a systemic disease with significant economic and welfare implications in poultry. This study aimed to determine the Infectious Dose 50 (ID50) of S. Gallinarum in Vanaraja layer chickens and evaluate histopathological changes and immune responses. Chickens were intraperitoneally inoculated with escalating doses of S. Gallinarum (2×10⁹, 4×10⁹, 8×10⁹, and 1.6×10¹⁰ CFU), and the ID50 was estimated to be approximately 8.0×10⁹ CFU. Higher doses induced clinical symptoms, including mortality and liver damage characterized by congestion and necrosis. Serum antibody responses, specifically IgG and IgA, were significantly elevated in a dose-dependent manner. Additionally, flow cytometry (FACS) analysis revealed a marked activation of CD3+, CD4+, and CD8+ T-cells, indicating robust cellular immunity. These findings underscore the pathogenicity of S. Gallinarum and highlight the need for enhanced biosecurity measures, improved management practices, and the development of vaccines to mitigate its impact on poultry health.
The development of advanced biomaterials with multifunctional properties is essential to address the complex challenges of impaired wound healing and tissue regeneration. This study introduces a novel composite scaffold (SSP–CG), in which silk sericin (SS) and polyvinyl alcohol (PVA) form the SSP component, while copper nanoparticles (CuNPs) and gallic acid (GA) constitute the CG component. SS provides biocompatibility and biodegradability, while PVA enhances structural integrity. CuNPs and GA impart antimicrobial and antioxidant activity, respectively, making the scaffold highly suitable for biomedical applications. The scaffold features an optimal pore size (96 ± 19 μm) and pore volume, promoting cell infiltration and nutrient diffusion. In vitro degradation studies revealed a controlled, sustained profile over 6 weeks, ideal for long-term therapeutic use. A gradual and prolonged release of GA ensured continuous antioxidant activity, confirmed by a DPPH assay showing significant free radical scavenging activity (40.5 ± 2.1%). In vitro studies further confirmed excellent biocompatibility, with optimal cell adhesion, proliferation, and viability while maintaining the environment for tissue regeneration. In vivo studies demonstrated superior wound healing outcomes for the SSP–CG scaffold compared to both positive and negative controls, with histological analysis further confirming enhanced tissue regeneration and reduced inflammation. This first-of-its-kind integration of SS, PVA, CuNPs, and GA highlights the synergistic benefits of these components, offering a promising solution for advanced wound healing and tissue regeneration. These findings suggest that SSP–CG scaffolds could contribute to next-generation biomaterials tailored for chronic wound management and regenerative therapies.
26 August 2025 in Journal of Materials Chemistry B
Correction for ‘SSP–CG scaffolds: a synergistic approach to enhance wound healing and tissue repair’ by Tasaduq Manzoor et al., J. Mater. Chem. B, 2025, 13, 9486–9497, https://doi.org/10.1039/D5TB00598A.